Scentian Bio raises GBP £5.5 million for food sensor
Fri, 10th Apr 2026
Scentian Bio has raised $7 million in an oversubscribed pre-Series A round led by Icehouse Ventures.
The New Zealand company is preparing to launch a handheld biosensor for food quality testing that combines engineered insect odour receptors with AI-based analysis. It has seven pilot customers in the food sector and expects to begin shipping within months.
Scentian Bio was spun out of the Bioeconomy Science Institute, formerly Plant and Food Research, following more than 20 years of research into insect biology. Its technology draws on the way insects detect volatile organic compounds, or VOCs, which are linked to factors such as fruit ripeness and disease markers in human breath.
The company has translated that research into synthetic odour receptors that can be connected to a transducer to create a biosensor. The device is designed to detect target VOCs and send data to the cloud, with food quality control as its initial market.
New investors Cultivate Ventures and NZGCP joined the round alongside existing backers Toyota Ventures, DYDX Capital, K1W1 and Booster. The Gates Foundation had previously awarded the company USD $2.7 million.
The new funding will be used to expand sales to food industry customers, establish manufacturing in Auckland, and build sales and support teams. Scentian Bio also plans to continue developing a next-generation version of its sensing platform for applications including environmental monitoring and health.
Food Focus
Its first commercial focus is food quality control, which the company describes as a global industry worth more than USD $8 billion. Ahead of launch, it has been working with large food companies, including food and flavour groups and producers of spices, condiments and beverages.
For manufacturers and ingredient suppliers, late detection of quality issues can lead to waste, rework, recalls and disputes. Scentian Bio says its approach is designed to support day-to-day operational decisions by shifting more testing from laboratories to operational settings.
"Food producers make high-stakes decisions every day. When you can detect issues earlier, you can act sooner, before issues emerge. This can reduce waste, rework and write-offs, protect brand trust, and strengthen assurance. Our aim is to shift testing from the lab to operations so food producers can get the best out of every ingredient," said Jonathan Good, Chief Executive and Co-Founder of Scentian Bio.
Investor Backing
Icehouse Ventures said the investment reflects both the breadth of the underlying sensing platform and the company's initial focus on food. It also sees opportunities in biosecurity, medical detection, environmental protection and wellness.
"Scentian Bio is a great example of New Zealand research translating into globally relevant technology," said Bex Gidall, Principal at Icehouse Ventures.
"What stood out to us as investors is the strength of the platform technology. Scentian is initially focused on food, but the underlying sensing technology also has applications across human and environmental health. Technologies with that breadth of application are rare, and it will be exciting to see how this 'digital nose' develops," Gidall said.
The platform is supported by patents and a team spanning biology, assay development and machine learning. At its core is the idea that biological sensing principles found in insects can be reproduced in a manufactured format for routine industrial use.
This places Scentian Bio among a group of companies applying synthetic biology and AI to industrial testing, as food producers face growing pressure to identify faults earlier in supply chains. The company is now setting up local manufacturing in Auckland as it moves toward its first commercial shipments.